Correction to: J Nanobiotechnol (2021) 19:100 https://doi.org/10.1186/s12951-021-00833-4
Following publication of the original article [1], the authors identified a change in the ‘Funding’ section. The complete ‘Funding’ section is given below
“This research was supported by Technology Innovation Program (20009663) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2018R1A6A1A03025582).” The original article has been revised.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
PadmanabhaRao Amarachinta, Garima Sharma and Noufel Samed contributed equally to this work
Contributor Information
Madhusudhan Alle, Email: allemadhusudhan@kangwon.ac.kr.
Jin-Chul Kim, Email: jinkim@kangwon.ac.kr.
Reference
- 1.Amarachinta PR, Sharma G, Samed N, Chettupalli AK, Alle M, Kim JC. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect. J Nanobiotechnol. 2021;19:100. doi: 10.1186/s12951-021-00833-4. [DOI] [PMC free article] [PubMed] [Google Scholar]